Inhibiting the Translocation of HMGB1 Alleviates Renal Ischemia–Reperfusion Injury by Cutting Down Inflammatory Cascade
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2025.02.050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Qian Wei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Sichuan Academy of Sciences & Sichuan Provincial People's Hospital, School of Medcine, University of Electronic Science and…. Hauptthemen laut MEDLINE: HMGB1 Protein, Reperfusion Injury, Kidney, Inflammation. Die Arbeit nennt 16 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Ischemia and reperfusion does damage to tissues and causes the decline of organ function though the inflammatory cascade. Noteworthy, HMGB1 possess a crucial role in promoting progression of these effects in kidney. The study aimed at ascertaining the concrete mechanism of HMGB1 triggering inflammatory cascade in renal ischemia-reperfusion injury (IRI). METHODS: IRI was induced in mice by clamping left renal arteries for 60 minutes followed by 24 hours of reperfusion with the removal of right kidney. The effects of HMGB1on IRI were evaluated by targeting creatinine, blood urea nitrogen, survival rates, renal morphology, and the translocation and secretion of HMGB1. In addition, the expression of Toll-like receptor 4, phosphorylated nuclear factor κB p65, nuclear factor κB p65, and inflammatory cascade molecules (interleukin [IL]-1β, and IL-6, and tumor necrosis factor-α) were carried out. RESULTS: Our results demonstrated that antibody against HMGB1 (anti-HMGB1) can improve the survival rate; decrease the expression of creatinine, blood urea nitrogen, Toll-like receptor 4, phosphorylated nuclear factor κB p65, IL-1β, IL-6, and tumor necrosis factor-α; reduce renal pathological injury; alleviate the secretion of HMGB1; and suppress the translocation of HMGB1 from nucleus into cytoplasm in IRI. Notably, recombinant HMGB1, the agonist of HMGB1, can alleviate the noted effects of anti-HMGB1 in IRI. CONCLUSION: HMGB1 can aggravate renal IRI by triggering the inflammatory cascade, the mechanism of which is associated with activating the Toll-like receptor 4-nuclear factor κB p65 signal pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Sichuan Academy of Sciences & Sichuan Provincial People's Hospital, School of Medcine, University of Electronic Science and Technology, Sichuan Clinical Research Center for Kidney Disease, Chen…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wei, Q., Wang, J., & Zhang, J. (2025). Inhibiting the Translocation of HMGB1 Alleviates Renal Ischemia–Reperfusion Injury by Cutting Down Inflammatory Cascade. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.02.050
Vancouver
Wei Q, Wang J, Zhang J. Inhibiting the Translocation of HMGB1 Alleviates Renal Ischemia–Reperfusion Injury by Cutting Down Inflammatory Cascade. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.02.050
BibTeX
@article{Wei2025,
author = {Wei, Qian and Wang, Jia and Zhang, Jiong},
title = {Inhibiting the Translocation of HMGB1 Alleviates Renal Ischemia–Reperfusion Injury by Cutting Down Inflammatory Cascade},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2025.02.050}
}
EUVIMED